Research output

  1. Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study

    Research output: Contribution to journalComment/Letter to the editorAcademic

  2. Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (29) »

ID: 91439